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Background: This study evaluated the influence of repeated anaesthesia using isoflurane (ISO, 2–3 Vol%), ketamine-
xylazine (KX, 100 mg·kg−1 + 5 mg·kg−1, i.m.) or a combination of medetomidine-midazolam-fentanyl (MMF, 0.15 mg·kg−1
+ 2.0 mg·kg−1 + 0.005 mg·kg−1, i.m.) on heart rate (HR), arterial blood pressure (BP), body temperature (BT), duration of
anaesthetic intervals and body weight (BW) in Wistar rats. Rats were instrumented with a telemetric system for the
measurement of systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), pulse pressure (PP), HR and BT during
induction, maintenance and recovery of anaesthesia. Each anaesthesia was performed six times within three weeks.
KX was not antagonized, but ISO delivery was terminated 40 minutes after induction and MMF was reversed with
atipamezole-flumazenil-naloxone (AFN, 0.75 mg·kg−1 + 0.2 mg·kg−1 + 0.12 mg·kg−1, s.c.).
Results: With repeated anaesthesia, ISO showed a decrease of HR and BP. A significant decrease of PP could be
observed with repeated anaesthesia using MMF. HR and BP were not affected by repeated KX anaesthesia, but we
noted a reduction of sleeping time and BW. Neither MMF nor ISO showed significant differences in the duration of
anaesthetic intervals and BW. With KX we observed tissue necrosis at the injection site and surgical tolerance was not
achieved in 25% of the anaesthesias performed.
Conclusion: HR, BP values, BT, duration of anaesthetic intervals and BW were affected differently by repeated
anaesthesia performed with ISO, KX or MMF. ISO produced a reproducible anaesthesia, thereby being suitable for
repeated use, but with a decrease of HR and BP throughout the six anaesthesias. The use of ISO in cases where these
parameters should be unaffected is therefore not advised. The inability to produce a surgical tolerance, the reduction of
sleeping time and BW, as well as the tissue necrosis are significant contraindications for a repeated use of KX. Only mild
changes of BP were found with repeated MMF anaesthesia, so it seems suitable for serial use, unless the high BP and
the low HR during the surgical plane of anaesthesia are undesirable for a special procedure.
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Repeated general anaesthesia may be required in animal
experiments several times a day, or on different days. This
might arise, for example, in longitudinal imaging studies,
in pharmacokinetic studies where a serial collection of
blood or other samples is required and in studies where
surgical procedures or drug administrations are performed
under anaesthesia on different days. Also in veterinary
practice, repeated anaesthesias may be required for some
therapeutic treatments (painful wound care, regular dental
care…) [1-4]. The rat is a commonly used laboratory
animal and has gained popularity as a pet [5]. For pro-
ducing general anaesthesia in the rat, isoflurane (ISO),
a mixture of ketamine-xylazine (KX) or a combination
of medetomidine-midazolam-fentanyl (MMF) have been
used [5-8]. In a previous study we have shown the influ-
ence of these anaesthesias on HR, SAP, DAP, MAP, PP and
BT in adult, male Wistar rats [9]. With ISO we observed a
significant increase of HR and a mild hypotension during
anaesthesia. A marked hypertension and a significant de-
crease of HR were seen during MMF anaesthesia. The
slightest alterations on the parameters measured were ob-
served with KX, but prolonged monitoring was needed,
because of long wake-up and recovery periods. It is not
known, however, if the effects observed change with re-
peated anaesthesia, which may be of importance, since
such changes could have an impact on the outcome of
studies requiring repeated anaesthesia. Some studies have
already evaluated influences of different anaesthetic re-
gimes on the animal’s physiology, but none of these
studies used telemetric data assessment to evaluate con-
tinuously alterations of HR, BP values and core BT before,
during and after anaesthesia. Radiotelemetry is regarded
as the state-of-the-art monitoring method to provide reli-
able values of cardiovascular parameters and body
temperature without stressful manipulations of the animal
which could affect the data collected [10-14].
The aim of this study was to assess the effects of re-
peated anaesthesia using ISO, KX or MMF in telemetri-
cally instrumented male Wistar rats on HR, SAP, DAP,
MAP, PP, BT and duration of different anaesthetic stages.
We hypothesized that change in the parameters mea-
sured would be observed with repeated anaesthesia. Fur-
ther it was our intention to assess BW during the series
of performed anaesthesias, because significant weight




Nine male Wistar rats with a mean body weight of 275 ±
24 g were obtained from Charles River Laboratories,
Sulzfeld, Germany. They were housed in groups of three
in a Makrolon® cage (Type IV). The cages contained awooden bedding material (Lignocel select fine, J.
Rettenmaier & Söhne GmbH+Co. KG, Rosenberg,
Germany) and as cage enrichment a wooden chewing
block and two red, transparent plastic tubes were pro-
vided. The cages were changed twice per week. Rats were
given free access to a commercially available diet (3438
maintenance diet, KLIBA NAFAG, Provimi Kliba AG,
Kaiseraugst, Switzerland) and tap water. The animals were
acclimated for two weeks prior to surgical implantation of
the radiotelemetry transmitter in an animal room main-
tained at 22 ± 2°C and 55 ± 10% relative humidity, on a
twelve-hour light–dark cycle (beginning at 6:00 am) with
at least 15 air changes per hour. A radio was turned on
during the working hours to reduce possible stress caused
by environmental noises. After the implantation surgery
and a rehabilitation period of at least two weeks, rats were
used in a previous anaesthetic study, which lasted nine
weeks [9]. The rats were then given a recovery period of at
least three weeks prior to the start of the present study. At
the beginning of the present study, the rats had a mean
body weight of 434 ± 48 g.
Radiotelemetry transmitter implantation surgery
The radiotelemetry transmitter (DSI PhysioTel™ C50-PXT)
was implanted under general anaesthesia. Anaesthesia was
induced with MMF (same dosage as used in this study) and
was maintained with a second injection of MMF (one third
of the initial dosage) after 45 minutes. Analgesics and antibi-
otics were administered prior to surgery: 50 mg·kg−1 metami-
zole i.m. (Novalgin®, 500 mg·ml−1, Sanofi Aventis, Frankfurt/
Main, Germany), 1 mg·kg−1 meloxicam s.c. (Metacam®,
20 mg·ml−1, Boehringer Ingelheim, Ingelheim/Rhein,
Germany), 10 mg·kg−1 enrofloxacin s.c. (Baytril® 2.5% ad us.
vet., Bayer, Leverkusen, Germany). After induction of an-
aesthesia, protective eye lubricant (VitA-POS, Ursapharm,
Saarbrücken, Germany) was administered in both eyes, the
rat was laid in a supine position in the middle of a water
heating pad, shaved on the ventral site and desinfected with
Kodan®-spray (Schülke & Mayr, Norderstedt, Germany)
and Betaisodona®-solution (Mundipharma GmbH, Limburg
(Lahn), Germany). Supplemental Oxygen was provided via
a head chamber throughout the anaesthesia. The rat was
covered with a sterile foil and an incision was made along
the linea alba to open the abdominal cavity. The intestines
were moved towards the diaphragm and held in position
with a wet swab. The aorta was exposed and blood flow
was stopped with two vascular clips. The blood pressure
catheter was inserted between the two clips and fixed with
one drop of tissue glue (Histoacryl®, B.Braun, Aesculap AG,
Tuttlingen, Germany). The clips were carefully opened and
the swab was removed. The transmitter was fixed with a
permanent suture (Mersilene® 3–0, Ethicon®, Johnson-
Johnson Medical GmbH, Norderstedt, Germany) to the ab-
dominal wall. Before the abdominal cavity was closed with
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Johnson Medical GmbH, Norderstedt, Germany), the ECG
leads were exteriorized through the muscle layer. One ECG
lead was placed subcutaneously near the sternum and the
other was placed on the ventral site of the trachea, both
fixed to the nearby muscle tissue with a non-absorbable su-
ture (Mersilene® 3–0, Ethicon®, Johnson-Johnson Medical
GmbH, Norderstedt, Germany). Twenty ml·kg−1 warmed
lactated ringer’s solution (Ringer-Lactat nach Hartmann B.
Braun, B/BRAUN, Melsungen, Germany) were adminis-
tered subcutaneously and anaesthesia was reversed with
a s.c. injection of AFN (same dosage as used in this
study). After surgery the rats received analgesics for an-
other two days.
Experimental design
The following three anaesthetic regimes were performed
repeatedly in male Wistar rats: 1) an inhalational anaesthe-
sia with 2–3 Vol% isoflurane (Forene® 100% (V/V), Abbott,
Wiesbaden, Germany) at maintenance, terminated after
40 minutes, 2) a combination of 100 mg · kg−1 ketamine
(Ketavet®, 100 mg·ml−1, Pfizer, Berlin, Germany) and
5 mg·kg−1 xylazine (Rompun® 2%, 20 mg·ml−1, Bayer,
Leverkusen, Germany) administered i.m., which was not
reversed, and 3) an anaesthesia consisting of 0.15 mg·kg−1
medetomidine (Domitor, 1 mg·ml−1, Orion Pharma, Espoo,
Finland), 2 mg·kg−1 midazolam (Dormicum®, 5 mg·ml−1,
Roche, Grenzach-Wyhlen, Germany) and 0.005 mg·kg−1
fentanyl (Fentanyl®-Janssen, 0.05 mg·ml−1, Janssen, Wien,
Austria), which was administered i.m. and antagonized
after 40 minutes with a s.c. injection of the antagonists
0.75 mg·kg−1 atipamezole (Antisedan®, 5 mg·ml−1, Orion
Pharma, Espoo, Finland), 0.2 mg·kg−1 flumazenil (Flumazenil
Hexal®, 0.1 mg·ml−1, Hexal, Holzkirchen, Germany) and
0.12 mg·kg−1 naloxone ( Naloxon Inresa, 0.4 mg·ml−1 l,
Inresa, Freiburg, Germany). Anaesthesias were performed
twice weekly (Monday + Thursday or Tuesday + Friday)
over three consecutive weeks. The six anaesthesias were
described in the following text as run 1 to run 6. The an-
aesthetic regimes were assigned randomly to each individ-
ual rat. Each rat received only two of the three anaesthetic
treatments for six times with a wash out and recovery
period of at least two weeks between them. SAP, DAP,
MAP, PP, HR and BT were measured continuously before,
during and after each anaesthesia. To monitor the anaes-
thetic depth, the righting reflex and the pedal withdrawal
reflex on the fore- and hind limbs were measured (classi-
fied with +, ±, and -) after 2.5, 5, 7.5, 10, 15, 20, 30, 40,
42.5, 45, 47.5, 50, 60, 70…minutes until the righting reflex
had returned. One run was divided into different intervals:
1) an acclimatization period prior to the anaesthesia of
at least two hours for assessing baseline values, 2) the
performance of anaesthesia, and 3) a recovery period. To
analyse alterations in the duration of the anaesthetic effect,the anaesthesia period was further divided in different an-
aesthetic stages: 1) induction time (defined as the time
from application to loss of the righting reflex), 2) time of
non-surgical tolerance (defined as the time from loss of
the righting reflex until loss of all reflexes tested), 3) time
of surgical-tolerance (defined as the time from loss of all
reflexes tested until regaining of at least one reflex), 4)
wake-up period (defined as the time from regaining the
first reflex until regaining the righting reflex) , and 5) re-
covery period (defined as the time from regaining the
righting reflex until measurement was terminated). The
end of measurement was not earlier than six hours after
induction. Sleeping times longer than six hours occurred
with KX, therefore data assessment was prolonged and
terminated not earlier than two hours after the righting re-
flex had returned. Additionally, each rat was weighed to
calculate the individual dose of injectable anaesthetics and
to assess a possible influence of repeated anaesthesia on
BW. Daily monitoring of the animals’ general condition
and well-being were carried out, especially with regard
to inflammation and tissue necrosis at the hind legs after
injection of anaesthetics. Only visible changes (open
wounds, lameness) were assessed, because the animals
were used in further studies.
The Animal Care and Ethics Committee of the Regional
Authority in Tuebingen, Baden-Wuerttemberg, Germany
approved this study (Approval number: 12–038).
Procedure
The experimental set-up was the same as that used in
the previous study [9]. To reduce variability, anaesthesias
were performed by the same veterinarian supported al-
ways by the same animal care takers, who were familiar
with the animals. To ensure a thorough monitoring of
each rat during anaesthesia, not more than three rats
were anaesthetized per day. The measurements have
been carried out in the same laboratory as described
below:
The implanted radiotelemetry transmitters of the three
rats were switched on using a magnet before starting the
measurements. The rats were then placed individually into
a Makrolon® cage, each positioned directly on a receiver
plate, and continuous data collection of arterial blood
pressure and BT was started. The cages contained bedding
material (Lignocel select fine, J. Rettenmaier & Söhne
GmbH+Co. KG, Rosenberg, Germany), a red, transparent
plastic tube and water was provided in a water bottle dur-
ing the entire measurement. Following recommendations
to pre-warm animals prior to anaesthetic induction, a
warm water heating pad was placed between the receiver
plate and the Makrolon® cage and it was maintained at
38°C throughout the measurement period [15,16]. To fa-
cilitate reaching resting baseline values, rats were housed
individually, food was withdrawn, each cage was covered
Albrecht et al. BMC Veterinary Research  (2014) 10:310 Page 4 of 15with a cloth, a radio was switched on (because rats were
habituated to background music), and the operator left
the room for at least two hours. After this acclimatization
period the operator started with the anaesthetic induction
of the first rat, while the other two rats remained in their
covered cages. Performing anaesthesia on one rat did not
appear to have an influence on the measured parameters
of the other two. All anaesthesias were carried out close to
the receiver plate to ensure the continuous capture of the
telemetric signal and are described in detail below:
ISO: An anaesthetic chamber was prefilled with 5 Vol%
ISO supplemented with oxygen. The rat was placed in the
whole body chamber, which was positioned directly on the
receiver plate. Loss of righting reflex was tested by tipping
over the anaesthetic chamber. When the righting reflex
was lost, the animal was laid on its back on the receiver
plate and ISO was administered using a nose cone.
The concentration of ISO was reduced to 2–3 Vol% to
maintain an anaesthetic depth of surgical tolerance.
ISO administration was terminated 40 minutes after
induction of anaesthesia and the rat was laid back in
its cage, which was placed on the receiver plate again.
The rat was positioned in a dorsal recumbency to test
reflexes until regaining the righting reflex.
KX: Ketamine (100 mg·kg−1) and xylazine (5 mg·kg−1)
were mixed in one syringe with a total volume of
1.25 ml·kg−1, which is too much to be injected all at
once. Therefore, half of this volume was administered
in the caudal part of the thigh muscle of each hind leg.
As soon as the righting reflex was lost, the rat was
placed directly on the receiver plate in dorsal recum-
bency. Oxygen was supplemented using a head chamber.
Rats received no treatment to reverse the anaesthesia.
Therefore, the duration of the sleeping time was vari-
able. Accordingly, rats were laid on their backs on the
receiver plate until the righting reflex returned and after
that they were put back in their cage for the rest of the
measurements. Wake-up and recovery periods lasted
several hours and therefore prevented a normal food
and water uptake. Therefore, each rat was administered
s.c. 5 ml of warmed lactated ringer’s solution (Ringer-
Lactat nach Hartmann B. Braun, B. Braun, Melsungen,
Germany) one hour after induction of anaesthesia.
MMF: 0.15 mg·kg−1 medetomidine, 2 mg·kg−1 midazo-
lam and 0.005 mg·kg−1 fentanyl were combined in one
syringe with a total volume of 0.65 ml · kg−1. The mix-
ture was administered i.m. in the caudal part of the thigh
muscle of one hind leg while holding the rat next to the
receiver plate. The rat was put back in its cage until loss
of the righting reflex. The rat was placed directly on the
receiver plate in dorsal recumbency and oxygen was pro-
vided using a head chamber. A mixture of antagonists
(0.75 mg·kg−1 atipamezole + 0.2 mg·kg−1 flumazenil +
0.12 mg·kg−1 naloxone) was administered s.c. 40 minutesafter induction of the anaesthesia and the rat was placed
in dorsal recumbency in its cage to determine the time
when the righting reflex was regained.
Statistical analysis
For the continuous telemetric data acquisition the soft-
ware NOTOCORD-hem™ was used and the raw data were
further evaluated with MS Excel with subsequent export
to SAS 9.3 (SAS Institute Inc., Cary, North Carolina, USA)
for the statistical evaluation. The statistical analysis was
performed separately for each treatment group (ISO, KX,
MMF), parameter (SAP, DAP, MAP, PP, HR, BT, BW) and
anaesthetic interval (induction time, time of non-surgical
tolerance, time of surgical tolerance, wake-up period, re-
covery period). The standardized area under the curve
(AUC divided by interval length) was calculated for each
animal individually using the trapezoidal rule for each an-
aesthetic interval. Baseline values were calculated for each
animal as the standardized AUC including the measure-
ments from 60 to 10 minutes before induction of anaes-
thesia. The standardized AUC was then used as target
variable for the statistical evaluation. The differences be-
tween the 1st run and its consecutive runs were analysed.
An analysis of covariance (ANCOVA) for repeated mea-
surements was calculated including baseline as covariate.
The parameter body weight was analysed by an analysis
of variance (ANOVA). In addition, the length of the in-
tervals was analysed using an ANOVA model for re-
peated measurements. To exclude effects of repeated
anaesthesia on baseline values, parameters were ana-
lysed during the baseline interval using an analysis of
variance (ANOVA). Treatment effects for the telemetry
parameters were quantified by mean differences, based
on the adjusted mean values and their two-sided 95%
confidence interval. Treatment effects for body weight
and the length of the intervals were quantified by the
differences in mean and their two-sided 95% confidence
interval. The level of significance was fixed at α = 5%. A
p-value of less than 0.05 was considered to be statisti-
cally significant.
Results
During the course of this study we had four runs that
needed to be excluded from the analysis. One rat anaes-
thetized with ISO in run 6 developed a poor blood pres-
sure signal and could not be evaluated. Another rat died
during induction of KX anaesthesia in run 6. With MMF
there was one rat in its 6th run with an elevated BT and
an increased HR already during the baseline assessment
such that we excluded that rat from the evaluation. Finally,
one rat had a failed application of MMF in its 4th run due
to strenuous defensive movements of the animal. There-
fore, these four measurements were excluded from the
statistical analysis of HR, BP values, BT and duration of
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tical analysis of BW.
Our intention to divide the anaesthesias in five differ-
ent anaesthetic stages failed for KX, because in 25% of
the anaesthesia runs with KX the animals did not reach
a stage of surgical tolerance. Instead of excluding these
measurements from the statistical analysis, we decided
to divide all KX anaesthesias (irrespective of whether or
not surgical tolerance was reached) only in three differ-
ent anaesthetic stages: 1) an induction time (time from
injection until loss of the righting reflex), 2) a time of
non-surgical tolerance (time from loss of the righting
reflex until regaining the reflex) and 3) a recovery
period (time from regaining the righting reflex until end
of measurement).Duration of anaesthetic stages
The mean durations of the different anaesthetic stages of
ISO, KX and MMF are depicted in Figures 1, 2 and 3, re-
spectively. Significant changes were seen for ISO in run 3,
when the stage of non-surgical tolerance and the time of
surgical tolerance were compared with the same stages of
run 1 and in run 5, when the wake-up period was com-
pared with the wake-up period of run 1. With KX signifi-
cant differences of anaesthetic durations were observed.
Induction times of run 2 and 4 were significantly shorter
than the induction time of run 1 and times of non-surgical
tolerance from run 3–6 were significantly shorter when
compared to run 1. For MMF, there were no significant
differences observed in the duration of any anaesthetic
stage between any of the runs.Figure 1 Mean duration of ISO anaesthesia. Duration of anaesthesia wa
difference (p value < 0.05) based on the ANOVA for the comparison of theHeart rate, blood pressure values and body temperature
The mean values of HR, BP values and BT of ISO, KX
and MMF anaesthesia with the statistical analysis are
presented in Tables 1, 2 and 3, respectively. No signifi-
cant differences were observed during baseline assess-
ment, except in run 3 and run 4 for BT in ISO
anaesthesia. The absolute differences of mean BT of run
3 and 4 to run 1 were only 0.22°C. These deviations were
judged to be of no clinical relevance.
ISO: During ISO the most significant alterations were
seen in HR. HR in run 3 and 5 during induction time, in
run 2–6 during time of non-surgical tolerance, in run 3–6
during time of surgical tolerance and in run 2–6 during
the wake-up period were significantly lower compared to
the HR of run 1 . For induction time, time of non-surgical
tolerance and time of surgical tolerance we noted a con-
tinuous decrease of HR with repeated anaesthesia. For
SAP, DAP and MAP significantly lower values were ob-
served during time of surgical tolerance if run 5 and 6
were compared with run 1. PP was significantly higher
during induction time in run 3 and 4 compared to run 1
and BT was significantly lower in run 6 during time of sur-
gical tolerance and during wake-up period compared to
run 1.
KX: With KX significant differences of BP values com-
pared to run 1 were only observed once during induction
time (SAP in run 4) and during the time of non-surgical
tolerance (DAP in run 6). PP was significantly higher dur-
ing induction time in run 2 and 4 and during recovery
period in run 4 and 6 if compared to run 1. During time
of non-surgical tolerance BT was significantly higher in
run 2, 4, 5 and 6, when compared to run 1.s divided in four different anaesthetic stages. *Statistical significant
anaesthetic stages of run 2–6 with the anaesthetic stage of run 1.
Figure 2 Mean duration of KX anaesthesia. Duration of anaesthesia was divided in two different anaesthetic stages. *Statistical significant
difference (p value < 0.05) based on the ANOVA for the comparison of the anaesthetic stages of run 2–6 with the anaesthetic stage of run 1.
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could be observed during the induction time. SAP and
MAP were significantly lower in run 2 compared to run
1. SAP was also significantly lower during time of non-
surgical tolerance in run 6 and during time of surgical
tolerance in run 3 and 5. During the wake-up period,
SAP and MAP showed significantly higher values in run
6 and during the recovery period SAP, DAP and MAP
were significantly higher in run 6 compared to run 1. PP
showed significantly lower values during induction timeFigure 3 Mean duration of MMF anaesthesia. Duration of anaesthesia w
difference (p value < 0.5) based on the ANOVA for the comparison of the a
not observed.in run 6, during time of non-surgical tolerance in run 5
and 6 and during time of surgical tolerance in run 3, 5
and 6, when each was compared to run 1 of its respect-
ive anaesthetic stage. A significantly higher HR could be
observed in run 6, if compared to the 1st run, during
induction time, time of non-surgical tolerance and
wake-up period. During the recovery period HR was sig-
nificantly higher in run 5 and 6, if compared to run 1.
BT was significantly higher in run 4 compared to run 1
during time of non-surgical tolerance.as divided in four different anaesthetic stages. A statistical significant
naesthetic stages of run 2–6 with the anaesthetic stage of run 1 was
Table 1 Isoflurane – mean values with standard deviation
Parameter Run Baseline Induction Non-surgical tolerance Surgical tolerance Wake-up Recovery
(No. of animals) Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
SAP (mmHg) 1 (6) 121 ± 11.33 141 ± 13.09 133 ± 15.24 117 ± 7.76 123 ± 12.44 122 ± 11.41
2 (6) 120 ± 11.55 140 ± 10.78 128 ± 16.02 113 ± 9.33 121 ± 10.11 122 ± 10.94
3 (6) 121 ± 7.72 140 ± 11.81 130 ± 12.45 114 ± 8.71 123 ± 8.63 122 ± 8.45
4 (6) 120 ± 13.04 139 ± 12.48 130 ± 12.84 111 ± 9.11 120 ± 12.45 119 ± 9.77
5 (6) 115 ± 18.93 134 ± 16.08 124 ± 18.84 104 ± 16.35* 112 ± 20.32 116 ± 14.24
6 (5) 120 ± 8.00 139 ± 9.83 129 ± 14.88 106 ± 12.51* 120 ± 16.26 121 ± 8.87
DAP (mmHg) 1 (6) 90 ± 7.73 106 ± 11.97 97 ± 12.48 85 ± 6.96 87 ± 11.22 92 ± 7.94
2 (6) 89 ± 10.32 105 ± 10.06 92 ± 14.54 81 ± 7.68 86 ± 7.95 91 ± 8.58
3 (6) 89 ± 6.26 103 ± 10.88 93 ± 9.52 82 ± 7.54 87 ± 5.22 91 ± 7.24
4 (6) 88 ± 9.13 102 ± 10.85 93 ± 9.39 79 ± 6.44 85 ± 7.16 90 ± 8.45
5 (6) 85 ± 11.05 101 ± 9.30 90 ± 10.33 75 ± 7.76* 80 ± 9.46 89 ± 8.00
6 (5) 89 ± 7.55 103 ± 6.26 93 ± 10.85 75 ± 7.84* 84 ± 9.10 91 ± 7.64
MAP (mmHg) 1 (6) 100 ± 8.43 118 ± 11.99 109 ± 13.10 96 ± 6.72 99 ± 11.21 102 ± 8.72
2 (6) 99 ± 10.48 116 ± 9.96 104 ± 14.79 92 ± 7.99 97 ± 8.36 101 ± 9.12
3 (6) 100 ± 6.46 116 ± 10.94 105 ± 10.21 93 ± 7.41 99 ± 5.71 102 ± 7.31
4 (6) 99 ± 10.20 115 ± 11.11 105 ± 10.28 90 ± 6.93 97 ± 8.68 100 ± 8.79
5 (6) 95 ± 13.43 112 ± 11.17 102 ± 12.93 85 ± 10.42* 90 ± 13.00 98 ± 9.86
6 (5) 100 ± 7.28 115 ± 7.01 105 ± 11.92 85 ± 9.16* 96 ± 11.40 101 ± 7.69
PP (mmHg) 1 (6) 32 ± 7.21 35 ± 6.27 36 ± 6.57 32 ± 5.69 35 ± 6.65 30 ± 6.49
2 (6) 31 ± 5.01 35 ± 5.63 35 ± 5.84 32 ± 4.55 35 ± 5.33 30 ± 5.14
3 (6) 32 ± 4.40 37 ± 5.07* 37 ± 5.89 32 ± 6.14 36 ± 6.83 31 ± 4.86
4 (6) 31 ± 6.06 37 ± 5.58* 37 ± 5.99 32 ± 5.72 35 ± 6.88 30 ± 3.14
5 (6) 29 ± 9.60 33 ± 9.24 34 ± 10.02 29 ± 9.63 32 ± 11.29 27 ± 7.66
6 (5) 31 ± 5.37 36 ± 6.44 36 ± 6.82 31 ± 6.47 35 ± 7.82 29 ± 5.18
HR (bpm) 1 (6) 307 ± 27.11 417 ± 37.53 385 ± 22.02 389 ± 20.42 420 ± 22.31 297 ± 16.06
2 (6) 291 ± 16.65 392 ± 33.78 364 ± 18.80* 379 ± 16.73 409 ± 19.53* 297 ± 16.66
3 (6) 295 ± 12.59 393 ± 26.09* 365 ± 15.65* 377 ± 20.73* 411 ± 20.94* 295 ± 11.67
4 (6) 297 ± 25.77 401 ± 28.61 366 ± 20.41* 373 ± 21.72* 407 ± 19.90* 284 ± 12.68*
5 (6) 288 ± 17.14 387 ± 29.30* 358 ± 18.14* 366 ± 16.16* 406 ± 16.86* 291 ± 9.42
6 (5) 298 ± 18.58 386 ± 41.82 352 ± 24.35* 367 ± 7.26* 412 ± 18.68* 289 ± 13.51
BT (°C) 1 (6) 37.62 ± 0.49 37.52 ± 0.50 37.48 ± 0.52 36.50 ± 0.45 36.11 ± 0.52 37.26 ± 0.21
2 (6) 37.46 ± 0.43 37.43 ± 0.34 37.35 ± 0.33 36.19 ± 0.37 35.71 ± 0.41 37.25 ± 0.16
3 (6) 37.40 ± 0.37* 37.30 ± 0.28 37.20 ± 0.35 36.22 ± 0.35 35.82 ± 0.47 37.19 ± 0.32
4 (6) 37.40 ± 0.37* 37.39 ± 0.22 37.29 ± 0.24 36.32 ± 0.17 35.90 ± 0.37 37.25 ± 0.18
5 (6) 37.46 ± 0.33 37.27 ± 0.29 37.17 ± 0.38 36.16 ± 0.27 35.72 ± 0.30 37.13 ± 0.32
6 (5) 37.56 ± 0.38 37.55 ± 0.25 37.45 ± 0.26 36.20 ± 0.52* 35.71 ± 0.60* 37.20 ± 0.12
*Statistical significant difference (p value ≤ 0.05) based on the ANCOVA with baseline as covariate for the comparison of anaesthetic stages between run 2–6
versus run 1.
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Mean BW including the statistical analysis is depicted
in Figure 4. No significant differences of BW could be
observed during repeatedly performed anaesthesia with
ISO. With KX a continuous decrease of BW was seenwith an increased number of performed anaesthesias.
The reduction of BW was significant from run 2 to 6, if
compared with run 1. A reduction of BW was signifi-
cant once for MMF in run 4, if compared to BW of
run 1.
Table 2 Ketamine-Xylazine– mean values with standard deviation
Parameter Run Baseline Induction Non-surgical tolerance Recovery
(No. of animals) Mean ± SD Mean ± SD Mean ± SD Mean ± SD
SAP (mmHg) 1 (6) 116 ± 11.27 130 ± 12.81 96 ± 12.38 104 ± 9.16
2 (6) 118 ± 11.85 133 ± 13.38 97 ± 7.07 106 ± 8.86
3 (6) 114 ± 7.93 134 ± 11.38 96 ± 10.78 106 ± 6.18
4 (6) 116 ± 10.03 138 ± 10.86* 95 ± 9.36 105 ± 6.09
5 (6) 115 ± 9.65 133 ± 6.83 100 ± 9.89 103 ± 5.40
6 (5) 115 ± 6.14 138 ± 6.62 102 ± 6.18 105 ± 4.85
DAP (mmHg) 1 (6) 85 ± 9.85 96 ± 9.39 68 ± 10.01 76 ± 6.38
2 (6) 88 ± 10.40 96 ± 13.27 69 ± 7.57 77 ± 8.68
3 (6) 86 ± 10.10 103 ± 7.13 69 ± 9.81 78 ± 6.66
4 (6) 87 ± 8.15 103 ± 8.76 69 ± 7.13 75 ± 2.87
5 (6) 86 ± 7.04 99 ± 7.09 72 ± 9.14 75 ± 2.57
6 (5) 84 ± 5.83 102 ± 6.44 71 ± 5.24* 74 ± 1.39
MAP (mmHg) 1 (6) 95 ± 10.13 108 ± 10.35 77 ± 10.65 85 ± 7.08
2 (6) 98 ± 10.40 108 ± 12.93 79 ± 6.68 87 ± 8.34
3 (6) 95 ± 8.86 113 ± 8.12 78 ± 9.29 87 ± 5.76
4 (6) 96 ± 8.40 115 ± 9.05 78 ± 6.92 85 ± 3.64
5 (6) 96 ± 7.24 110 ± 6.16 81 ± 8.42 84 ± 2.20
6 (5) 95 ± 5.50 114 ± 6.35 81 ± 5.07 85 ± 2.39
PP (mmHg) 1 (6) 31 ± 4.42 34 ± 5.40 28 ± 4.52 28 ± 4.74
2 (6) 30 ± 6.95 36 ± 6.67* 28 ± 6.76 29 ± 5.51
3 (6) 28 ± 6.89 32 ± 7.08 27 ± 8.65 27 ± 6.39
4 (6) 30 ± 5.73 35 ± 6.20* 27 ± 8.29 30 ± 4.57*
5 (6) 29 ± 7.22 33 ± 7.09 28 ± 8.86 28 ± 6.47
6 (5) 31 ± 4.71 36 ± 2.97 31 ± 4.91 31 ± 3.94*
HR (bpm) 1 (6) 283 ± 36.14 354 ± 38.00 273 ± 23.56 288 ± 19.35
2 (6) 284 ± 20.10 375 ± 45.16 281 ± 20.12 292 ± 12.37
3 (6) 278 ± 14.31 359 ± 33.95 273 ± 19.86 296 ± 21.69
4 (6) 281 ± 22.22 340 ± 28.56 275 ± 35.47 290 ± 27.95
5 (6) 285 ± 20.98 362 ± 31.88 275 ± 29.33 292 ± 13.50
6 (5) 282 ± 21.89 362 ± 10.24 269 ± 21.50 277 ± 18.54
BT (°C) 1 (6) 37.39 ± 0.59 37.34 ± 0.63 36.96 ± 0.48 37.57 ± 0.47
2 (6) 37.49 ± 0.27 37.44 ± 0.22 37.34 ± 0.32* 37.79 ± 0.32
3 (6) 37.42 ± 0.19 37.27 ± 0.24 37.18 ± 0.37 37.72 ± 0.31
4 (6) 37.59 ± 0.23 37.40 ± 0.26 37.35 ± 0.45* 37.54 ± 0.53
5 (6) 37.56 ± 0.37 37.55 ± 0.39 37.46 ± 0.45* 37.79 ± 0.32
6 (5) 37.73 ± 0.48 37.58 ± 0.58 37.43 ± 0.36* 37.79 ± 0.08
*Statistical significant difference (p value ≤ 0.05) based on the ANCOVA with baseline as covariate for the comparison of anaesthetic stages between run 2–6
versus run 1.
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Clinical effects on the hind legs were seen in four rats
anaesthetized with KX (a total of six rats were repeatedly
anaesthetized with KX). In two rats we observed tissue ne-
crosis on the right hind leg. Both hind legs were affectedwith necrotic lesions in two other rats. The time of the first
occurrence of the tissue necrosis differed between the four
rats. The earliest occurrence of the necrosis was one day
after the second anaesthesia in two rats and the other ne-
crosis occurred after the fourth and fifth run with KX.
Table 3 Medetomidine-midazolam-fentanyl – mean values with standard deviation
Parameter Run Baseline Induction Non-surgical tolerance Surgical tolerance Wake-up Recovery
(No. of animals) Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
SAP (mmHg) 1 (6) 117 ± 5.42 158 ± 19.28 160 ± 21.24 157 ± 23.24 101 ± 15.20 113 ± 9.43
2 (6) 111 ± 7.34 144 ± 19.22* 151 ± 24.77 151 ± 25.47 105 ± 15.15 113 ± 7.08
3 (6) 112 ± 9.32 153 ± 18.24 152 ± 23.21 147 ± 24.90* 101 ± 13.70 115 ± 7.90
4 (5) 116 ± 8.18 149 ± 19.24 157 ± 28.86 146 ± 20.77 102 ± 11.90 114 ± 11.13
5 (6) 115 ± 6.49 153 ± 19.81 154 ± 21.44 146 ± 25.10* 103 ± 10.03 117 ± 9.90
6 (5) 117 ± 11.54 150 ± 17.01 146 ± 14.86* 148 ± 26.76 109 ± 17.16* 121 ± 11.21*
DAP (mmHg) 1 (6) 89 ± 4.40 120 ± 15.38 112 ± 7.78 107 ± 12.31 76 ± 13.69 90 ± 11.00
2 (6) 84 ± 7.51 112 ± 10.63 106 ± 12.00 103 ± 12.22 81 ± 10.84 90 ± 6.40
3 (6) 84 ± 5.49 117 ± 12.26 108 ± 9.00 103 ± 11.24 77 ± 11.00 91 ± 9.09
4 (5) 89 ± 13.66 114 ± 6.48 111 ± 15.30 101 ± 6.64 76 ± 4.93 91 ± 13.87
5 (6) 87 ± 5.85 116 ± 9.81 112 ± 8.85 103 ± 9.61 78 ± 8.78 92 ± 10.43
6 (5) 89 ± 12.07 117 ± 10.93 110 ± 7.56 106 ± 10.62 84 ± 12.95 97 ± 11.12*
MAP (mmHg) 1 (6) 98 ± 2.90 132 ± 15.27 128 ± 10.61 123 ± 14.23 84 ± 13.90 98 ± 10.09
2 (6) 93 ± 6.90 123 ± 12.88* 121 ± 15.41 119 ± 15.59 89 ± 12.11 98 ± 6.27
3 (6) 93 ± 5.91 129 ± 12.90 123 ± 12.68 118 ± 14.39 85 ± 11.55 99 ± 8.38
4 (5) 98 ± 11.61 126 ± 9.62 126 ± 19.01 116 ± 10.48 84 ± 6.59 99 ± 12.78
5 (6) 96 ± 5.27 128 ± 12.79 126 ± 12.53 117 ± 14.16 86 ± 8.81 101 ± 9.98
6 (5) 98 ± 11.39 128 ± 12.03 122 ± 8.47 120 ± 15.02 93 ± 14.07* 105 ± 10.66*
PP (mmHg) 1 (6) 28 ± 8.01 38 ± 14.80 48 ± 18.77 51 ± 18.78 25 ± 6.32 23 ± 6.17
2 (6) 27 ± 5.94 33 ± 12.11 45 ± 16.81 48 ± 18.10 24 ± 6.08 23 ± 4.64
3 (6) 28 ± 7.98 36 ± 14.18 43 ± 18.11 44 ± 19.42* 24 ± 6.67 24 ± 5.03
4 (5) 27 ± 7.33 35 ± 16.25 46 ± 18.03 45 ± 16.88 27 ± 9.47 23 ± 5.29
5 (6) 28 ± 6.38 37 ± 11.88 42 ± 14.75* 43 ± 17.89* 25 ± 5.78 24 ± 5.08
6 (5) 28 ± 7.29 33 ± 11.90* 36 ± 13.39* 42 ± 19.92* 25 ± 7.30 24 ± 6.96
HR (bpm) 1 (6) 289 ± 23.42 285 ± 37.92 211 ± 16.99 197 ± 19.63 249 ± 19.49 275 ± 15.28
2 (6) 274 ± 14.20 285 ± 45.73 214 ± 14.44 195 ± 15.42 255 ± 23.43 276 ± 15.52
3 (6) 277 ± 19.13 298 ± 26.01 215 ± 17.93 194 ± 16.58 247 ± 11.99 274 ± 19.53
4 (5) 282 ± 30.50 290 ± 26.66 214 ± 15.00 193 ± 15.97 251 ± 15.56 278 ± 20.03
5 (6) 276 ± 18.01 290 ± 39.66 212 ± 15.61 193 ± 13.88 257 ± 30.82 282 ± 24.58*
6 (5) 271 ± 15.55 298 ± 42.95* 215 ± 13.24* 191 ± 9.46 272 ± 43.96* 279 ± 26.52*
BT (°C) 1 (6) 37.50 ± 0.21 37.18 ± 0.16 36.88 ± 0.25 36.09 ± 0.17 35.67 ± 0.20 37.17 ± 0.58
2 (6) 37.48 ± 0.34 37.44 ± 0.31 37.05 ± 0.34 36.11 ± 0.25 35.65 ± 0.17 37.14 ± 0.48
3 (6) 37.27 ± 0.29 37.17 ± 0.36 36.86 ± 0.25 36.07 ± 0.26 35.66 ± 0.36 37.14 ± 0.36
4 (5) 37.58 ± 0.31 37.50 ± 0.37 37.24 ± 0.36* 36.28 ± 0.24 35.78 ± 0.25 37.32 ± 0.26
5 (6) 37.46 ± 0.19 37.13 ± 0.39 36.94 ± 0.42 36.08 ± 0.36 35.63 ± 0.28 37.23 ± 0.31
6 (5) 37.28 ± 0.28 37.18 ± 0.15 36.90 ± 0.16 35.96 ± 0.35 35.53 ± 0.42 37.38 ± 0.29
*Statistical significant difference (p value ≤ 0.05) based on the ANCOVA with baseline as covariate for the comparison of anaesthetic stages between run 2–6
versus run 1.
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This study investigated if repeated anaesthesia with ISO,
KX or MMF alter their influence on HR or BP values,
BT and BW of male Wistar rats. To our knowledge, it
was the first time that these parameters, together with
the duration of anaesthetic intervals were evaluatedduring repeatedly performed anaesthesia using telemet-
ric data assessment.
Effects on duration of anaesthesia
ISO: The significant differences in duration of anaesthetic
stages we observed with ISO occurred only sporadically,
Figure 4 Mean body weight. *Statistical significant difference
(p < 0.05) based on the ANOVA for the comparison of body weight
between run 2–6 versus run 1.
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the time of surgical tolerance (run 3) and once in the wake-
up period (run 5). It must be kept in mind, however, that
each rat needed a slightly different concentration of ISO
(between 2–3 Vol%) to reach a defined stage of anaesthesia.
This resulted in different times to adjust the ISO. Further-
more, the total length of surgical tolerance depended on
the duration of the induction time and time of non-
surgical tolerance, because we terminated ISO delivery
after 40 minutes. Thus, it seemed inappropriate to inter-
pret the duration of non-surgical and surgical tolerance.
Finally, since the absolute differences in the durations were
less than three minutes, we do not classify these differences,
despite statistical significant, as being clinically relevant.
KX: With KX there was tendency for the sleeping time
to decrease from run 1 to run 6. These findings are in ac-
cordance with other studies evaluating the sleeping time
during ketamine or ketamine-medetomidine anaesthesia
in which the authors suggested an increased induction of
metabolizing enzymes, which resulted in an increased
clearance of the anaesthetics [17-21]. In one of these stud-
ies the authors stated that the hypnotic effect was caused
by a specified plasma level of ketamine in the brain and
that the duration of anaesthesia depends on the speed of
tissue redistribution and metabolization [18]. Further-
more, a faster ketamine metabolism during anaesthesia
has been demonstrated after a daily low-dose ketamine
pretreatment over ten days, which is consistent with there
being an increase in metabolizing enzymes [17,20]. We
suggest that similar mechanisms may have caused the de-
crease of sleeping time after repeatedly performed KX an-
aesthesia in the present study. A relationship between the
continuous reduction of sleeping time and the failure to
reach surgical tolerance was not observed, because some
rats failed to reach this stage in almost all runs (except in
run 4) and therefore this was not associated with the in-
creased number of anaesthesias. The inconsistence ofketamine-xylazine to produce anaesthesia of sufficient
depth has been reported in previous studies [22,23]. This
effect has also been observed with the combinations of
ketamine-medetomidine or ketamine-dexmedetomidine
[24]. Since it was also suggested that the risk of anaesthetic
mortality may increase with the application of higher dos-
ages, we chose not to increase the ketamine-xylazine dos-
age in this study [23].
MMF: With MMF no significant differences in the
duration of the anaesthetic stages were observed with re-
peated anaesthesia. In contrast to KX, MMF was antago-
nized after 40 minutes. Therefore, it was not possible to
detect a change in whole sleeping time even if there had
been an increase of metabolizing enzymes. It would be
possible if rats became conscious before antagonization,
but this did not occur in this study. As with ISO we
were not able to evaluate alterations of the time of surgi-
cal tolerance, but for induction time, time of non-
surgical tolerance and wake-up period, repeated MMF
anaesthesia had no effect.
Effects on heart rate, arterial blood pressure and body
temperature
ISO: With repeated anaesthesia using ISO, there was a
decrease in arterial BP. The decrease was significant
from run 5–6 in comparison to run 1 during the time of
surgical tolerance. Significant lower HR compared to
run 1 could also be observed during the induction time,
time of non-surgical and surgical tolerance and wake-up
period in almost all subsequent runs (run 2–6). The HR
decrease is depicted in Figure 5. This was an unexpected
effect, because with decreasing BP values one would
usually expect a compensatory increase of HR through
baroreceptor-mediated effects. It seemed that the de-
pressant effect of ISO on BP became more pronounced
with an increased number of performed anaesthesias,
but the ability to compensate for this BP decrease with
an increased HR also diminished. Repeated ISO anaes-
thesia did not have any effect on myocardial, anatomical
or histological endpoints in previous studies [25,26]. A
further study noticed no significant QT prolongation in
the ECG, no myocardial repolarization abnormalities or
any evidence for left ventricular enlargement after re-
peated anaesthesia with ISO [27]. Taken together, a
histopathological explanation for the sequential depres-
sion of HR and BP appears not to be the case. Another
aspect could be that the ISO concentration was adapted
to the needs of each individual rat (2–3 Vol%). This vari-
able, not standardized ISO concentration could have had
an influence on the measured parameters. The decreases
in BP and HR we observed during six anaesthesias were
not severe enough to require intervention and are not
interpreted to be indicative of acute heart failure.
Whether or not the extent of the decrease in HR and BP
Figure 5 Isoflurane – Heart rate. Individual values per animal (colour highlighted symbols) and adjusted mean (−) by anaesthetic interval.
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were performed is not known. The significant increase
of PP observed during induction time in run 3 and 4
were not associated with significant differences of the
absolute BP values in the same runs and these two PP
values were still well within the physiological range [5].
Therefore, we concluded that the observed increase of
PP had no clinical relevance. In run 6 BT was signifi-
cantly lower compared to run 1 in time of surgical toler-
ance and wake-up period. A possible explanation could
be the lower BP values in run 6, due to the vasodilative
effects of ISO, leading to a greater heat loss during an-
aesthesia [6].
KX: The significant changes of BP parameters during
repeated KX anaesthesia occurred sporadically and did
not correlate with the different anaesthetic stages. In our
previous study, which evaluated the effect of a single KX
anaesthesia, we observed similar BP values compared to
those indicated to be different compared to run 1, sug-
gesting that changes were without clinical relevance,
since all values were within normal, physiological ranges
[5,9,28]. During the time of non-surgical tolerance BT
showed a tendency to increase and was significantly dif-
ferent to run 1 in run 2, 4, 5 and 6. As mentioned above,
the duration of this anaesthetic stage decreased progres-
sively from run 1–6. It is well known that anaesthetics
influence the thermoregulatory control and that espe-
cially small animals, like rodents, due to their large sur-
face area to body weight ratio, lose heat rapidly and may
become hypothermic during prolonged anaesthesia [6,8].
With the duration of anaesthesia becoming shorter from
run 1–6, there was less time for the rats to lose bodyheat and therefore, BT was comparatively higher during
the time of non-surgical tolerance. One animal receiving
KX died during its sixth anaesthesia. After injection of the
anaesthetics the rat immediately lost its righting reflex. HR
and BP decreased markedly and the animal stopped
breathing. Different mortality rates have been reported
previously for ketamine-xylazine, but without post-mortem
data we could not exclude any other factors (e.g. latent in-
fections) that may have contributed to the rat’s death
[23,29]. Many investigators now use ketamine combined
with medetomidine or dexmedetomidine rather than xyla-
zine. Anaesthesia of similar quality and depth was reported
for the combination of ketamine-xylazine and ketamine-
dexmedetomidine in rats [30]. Another study evaluating
the effects of repeated ketamine-medetomidine anaesthesia
reported that anaesthesia was not associated with anaes-
thetic mortalitiy, but in combination with buprenorphine
they observed an increased risk of anaesthetic related
death [31].
MMF: From induction time to the time of surgical tol-
erance a slight decrease of BP values, especially PP,
could be observed from run 1–6, whereas during wake-
up and recovery periods BP parameters slightly in-
creased with a significant difference only observed in
run 6. HR tended to increase from run 1–6 but not dur-
ing the time of surgical tolerance. The increased HR was
only significant, however, in run 6. In a previous report
on the effects of repeated MMF anaesthesia in rats, the
authors observed only a slight decrease of a vitality index
(escape reaction, aggressiveness, speed of movements
and paresis were classified and scored) [32]. They did
not observe significant differences of HR and BT when
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In our previous study we observed significant increases
of all BP values, with PP almost doubled compared to its
baseline value and HR was significantly decreased during
MMF anaesthesia [9]. As also seen in this study, a rapid
and short-lasting decrease of BP values occurred after
antagonism. We noted that the BP values of run 1 were
already lower compared to the values of this single
MMF anaesthesia, although we had expected approxi-
mately similar values at least during the 1st run of MMF
anaesthesia. Furthermore, we observed a much larger
variability with the repeated anaesthesia compared to
the variability seen with the same anaesthetic stages in
the previous study. Baseline values of these two studies
were comparable, therefore, the cardiovascular condition
of the rats and the quality of the telemetric signal were
comparable during time of anaesthetic induction. We
conclude, therefore, that the effect of MMF anaesthesia
on haemodynamic parameters was indeed more variable
as in the previous study. An example of the great inter-
individual difference of PP values is depicted in Figure 6.
We noticed that the anaesthetic profiles were most simi-
lar to the previous study with the youngest animal in the
group, whereas lowest BP values during MMF anaesthe-
sia were mostly seen in the older animals. The differ-
ences of run 1 compared to the values of the previous
study could be related to the different ages of the rats
(maximum of five months age difference). It is known
that metabolism and mechanisms of the autonomic ner-
vous system and cardiovascular system undergo age-
related changes [6,33]. Effects of age have been describedFigure 6 Medetomidine-midazolam-fentanyl – Pulse pressure. Individu
(−) by anaesthetic interval.for other anaesthetic regimes, but have not yet been re-
ported for haemodynamic parameters during MMF treat-
ment [34,35]. BT was not affected substantially by
repeated anaesthesia, with only one significant difference
during time of-non surgical tolerance in run 4. If we com-
pared the BT of the repeated anaesthesia with the BT
values of the previous study, there was a difference of al-
most one degree, especially during time of surgical toler-
ance and wake-up period, although the same conditions
were provided to maintain heat throughout the measure-
ments [9]. Baseline values of BT and recovery values of
these two studies were comparable. Therefore, the influ-
ence of MMF anaesthesia on BT in the two studies ap-
pears to be different. Fentanyl and midazolam have only
little effect on BP values, but medetomidine is known to
cause a vasoconstriction in the peripheral circulation and
loss of body heat depending, among other things, on the
perfusion of the periphery [5,6]. Medetomidine might have
caused a less intensive vasoconstriction which resulted in
lower BP values in this study compared to the values of
the previous study. An effect of age or BW could also be
responsible, but BT with ISO or KX anaesthesia was com-
parable between the two studies and there were the same
differences in age and BW. Therefore, an age- or BW-
related effect seems unlikely. Nevertheless, the effect on
BT was consistent within the three weeks of performing
six MMF anaesthesias.
Effects on body weight
BW did not alter significantly during the three weeks of
repeated ISO and MMF anaesthesia, except at one timeal values per animal (colour highlighted symbols) and adjusted mean
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BW reduction of less than 1% compared to the BW in
run 1. Hence, it is not of clinical relevance, since BW
remained unaffected in the following runs using MMF
anaesthesia. A continuous decrease of BW was observed
with KX, however. The reduction of mean BW from run
1–6 was nearly 8%. This could be due to the long sleep-
ing time and recovery period, such that the rats ate and
drank less. Another negative effect on food and water
uptake could be the disturbing influence of ketamine on
the circadian rhythm of the animal [36,37]. The serious-
ness of a BW loss of 8% depends on the initial body
weight of the animal. Decreases in body weight in the
range of 15-30%, alone or in combination with a poor
general condition, have been used in the past to indicate
the necessity for a humane endpoint of a test animal
[38,39]. We did not reach a BW loss of this extent after
performing six anaesthesias within three weeks, but it
could be more pronounced if performing more than 6
runs or reducing the time between two anaesthesias.
Furthermore, one has to consider the additional influ-
ence of experimental procedures (surgery, drug applica-
tion, etc.) on BW.
Effects of administration route
No obvious detrimental effects could be observed with
repeated ISO inhalation or i.m. administration of MMF,
but with KX, we often noticed visible tissue necrosis at
the injection site. A reason could be the administered
volume of anaesthetics. The injected volumes of KX and
MMF in this study appear higher than volumes recom-
mended for intramuscular injection in rats in some
guidelines [40]. However, recommendations are typically
given in volume per animal (ml) as opposed to volume
per kg body weight. The rats used in this study had a
mean body weight of 434 ± 48 g and thus were substan-
tially heavier than commonly used laboratory rats. We
chose not to administer the anaesthetics intraperitone-
ally, because of the presence of the telemetry device in
the abdominal cavity and the risk to damage the cables
during injection. Additionally, peritonitis as a result of
intraperitoneal injection of irritants would be associated
with more complications in rats implanted with a telem-
etry device. Furthermore, an intraperitoneal injection
has a risk to be misdirected into the gastrointestinal
tract or the urinary bladder [6,41,42]. This depends on
how familiar one is with the technique and differed
between personnel. The variable failure rate may have
serious consequences for analysis and data interpretation
[43,44]. We suggest that the acidic formulation of keta-
mine, and not the injected volume, caused these necrotic
lesions, because the injected volume of KX at each injec-
tion site was comparable with that of MMF. Of course,
we cannot exclude the possibility, that also MMF causednecrotic lesions to a lesser extent, which were not obvious
visible during our daily clinical monitoring. Histological
examinations, which were not carried out in this study,
are required to clarify the tissue response after an intra-
muscular injection of MMF. We treated the wounds at the
injection sites daily with an ointment (Pana Veyxal® Salbe,
Veyx-Pharma GmbH, Schwarzenborn, Germany) to accel-
erate the healing process, but with an increased number of
performed KX anaesthesias, the tissue necrosis became
worse. The size of the necrosis did not become too large,
so that an injection of subsequent KX administrations in
healthy tissue was still possible. The absorption of drugs
injected in inflamed muscle tissue is different due to an al-
tered tissue pH and an increased vascularization [45,46].
Duration and depth of anaesthesia could be influenced as
well as HR, BP and BW. Therefore, a comparison of an-
aesthesias injected in healthy and inflamed tissue is not
advisable.
Altogether, with regard to a low-stress administration
and smooth and rapid induction of anaesthesia, ISO of-
fers a clear advantage compared to the injectable anaes-
thetics. Additionally, it cannot be denied that ISO is only
minimally metabolized compared to the other anaes-
thetics, easily adjustable to the individual needs of each
animal and simple to handle and to prolong the duration
of anaesthesia if needed. These advantageous aspects of
ISO have to be taken into consideration for the repeated
use, unless the experimental procedure would not allow
an inhalational anaesthetic regimen.Conclusion
Our study evaluated the effect of repeated anaesthesia
with ISO, KX or MMF on HR, SAP, DAP, MAP, PP, BT,
duration of anaesthetic intervals and BW in male Wistar
rats.
With the decrease of HR and BP during the six repeti-
tive ISO anaesthesia, the use of ISO has to be considered
if a change of these parameters is not acceptable for a
given study design. Otherwise, ISO is well-suited for serial
use, since it is possible to produce anaesthesia with com-
parable duration and depth and it has some advantageous
aspects compared to the injectable regimes. With the in-
ability to consistently produce a surgical plane of anaes-
thesia and the reduction of sleeping time and BW, as well
as the frequent production of a local tissue necrosis at the
injection site, KX has some distinct disadvantages. Al-
though HR, BP values and BT remained unaffected after
six KX anaesthesias, the other results of this study may be
considered significant contraindications for the repeated
use of KX. With only mild changes of BP values with re-
peated anaesthesia, MMF seems suitable for serial use, un-
less the high BP and the low HR during the surgical plane
of anaesthesia are undesirable.
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